Construction of a Cuproptosis-Related lncRNA Prognostic Model for Bladder Urothelial Carcinoma and Screening of Potential Drugs

Figure 2

Screening for cuproptosis-related lncRNA of greater prognostic value in patients with BLCA. (a) Univariate Cox analysis of lncRNA associated with cuproptosis. (b) and (c) Lasso regression analysis of lncRNA associated with cuproptosis.

(a)

(b)

(c)